Published in Brain on January 09, 2006
Patterns of treatment response in newly diagnosed epilepsy. Neurology (2012) 2.76
Complete remission of childhood-onset epilepsy: stability and prediction over two decades. Brain (2014) 1.69
Complete remission in nonsyndromic childhood-onset epilepsy. Ann Neurol (2011) 1.64
New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov (2013) 1.63
Seizure remission and relapse in adults with intractable epilepsy: a cohort study. Epilepsia (2008) 1.58
Long-term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy. Dev Med Child Neurol (2014) 1.40
AED discontinuation may not be dangerous in seizure-free patients. J Neural Transm (Vienna) (2010) 1.25
Anti-epileptogenic clinical trial designs in epilepsy: issues and options. Neurotherapeutics (2014) 1.16
AED discontinuation may be dangerous for seizure-free patients. J Neural Transm (Vienna) (2010) 1.14
Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects. Curr Neuropharmacol (2009) 1.05
Refractory epilepsy: one size does not fit all. Epilepsy Curr (2007) 1.04
Deep brain stimulation for epilepsy. Neurotherapeutics (2008) 0.98
Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr (2008) 0.98
Response to placebo in clinical epilepsy trials-Old ideas and new insights. Epilepsy Res (2016) 0.96
Depression and anxiety in people with epilepsy. J Clin Neurol (2014) 0.93
The "natural" history of medically treated temporal lobe epilepsy: what can an evidence-based approach tell us? Epilepsy Res Treat (2012) 0.92
Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: a retrospective, population-based study. Epilepsia (2012) 0.90
Management of the patient with medically refractory epilepsy. Expert Rev Neurother (2009) 0.86
New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr (2009) 0.86
Pediatric indications for deep brain stimulation. Childs Nerv Syst (2012) 0.85
Astroglial networks and implications for therapeutic neuromodulation of epilepsy. Front Comput Neurosci (2012) 0.85
Seizure treatment in transplant patients. Curr Treat Options Neurol (2012) 0.84
Treatment strategy for the patient with hippocampal sclerosis who failed to the first antiepileptic drug. J Epilepsy Res (2014) 0.83
Surgical management of epilepsy. CMAJ (2014) 0.82
Seizure suppression through manipulating splicing of a voltage-gated sodium channel. Brain (2015) 0.81
Functional magnetic resonance imaging networks induced by intracranial stimulation may help defining the epileptogenic zone. Brain Connect (2014) 0.80
Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy. Epilepsia Open (2016) 0.77
Association of MDR1 gene C3435T polymorphism with childhood intractable epilepsy: a meta-analysis. J Neural Transm (Vienna) (2014) 0.77
Surgical treatment of epilepsy. Continuum (Minneap Minn) (2013) 0.77
Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis. BMJ Case Rep (2013) 0.77
Acute administration of the small-molecule p75(NTR) ligand does not prevent hippocampal neuron loss or development of spontaneous seizures after pilocarpine-induced status epilepticus. J Neurosci Res (2014) 0.76
A prospective cohort study of prognosis for newly diagnosed epilepsy in east China. BMC Neurol (2013) 0.76
Epilepsy surgery: recommendations for India. Ann Indian Acad Neurol (2010) 0.76
Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2). Epilepsy Behav (2013) 0.76
Predicting the Course of Childhood Epilepsy: More Uncertain Than Ever. Epilepsy Curr (2015) 0.75
Long-term outcomes of childhood epilepsy: "the truth is rarely pure and never simple". Epilepsy Curr (2007) 0.75
Old versus New: Why Do We Need New Antiepileptic Drugs? J Epilepsy Res (2014) 0.75
Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort. Neurology (2016) 0.75
Intractable epilepsy: relapsing, remitting, or progressive? Epilepsy Curr (2010) 0.75
How to Advance the Debate on Nonspecific vs Specific Seizure Type and Comorbidity Profile. Epilepsy Curr (2014) 0.75
Stress and seizure control in children: where to now? Epilepsy Curr (2013) 0.75
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy. Pharmaceuticals (Basel) (2010) 0.75
Honing in on risk factors for prolonged remission off medication by reducing heterogeneity. Epilepsy Curr (2012) 0.75
Characteristics of seizure frequency among Malaysian children diagnosed with structural-metabolic epilepsy. J Neurosci Rural Pract (2012) 0.75
Are we too pessimistic about drug-resistant epilepsy? Epilepsy Curr (2012) 0.75
Long-term prognosis in intractable epilepsy: looking beyond a year. Curr Neurol Neurosci Rep (2007) 0.75
Impact of aggression, depression, and anxiety levels on quality of life in epilepsy patients. Neuropsychiatr Dis Treat (2016) 0.75
Elemental changes in the hippocampal formation following two different formulas of ketogenic diet: an X-ray fluorescence microscopy study. J Biol Inorg Chem (2015) 0.75
Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr (2017) 0.75
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia (2009) 2.38
Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology (2010) 2.21
Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia (2011) 2.08
Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia (2012) 2.06
The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia (2008) 1.91
Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav (2005) 1.78
New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov (2013) 1.63
High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol (2005) 1.51
New Horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res (2006) 1.32
Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia (2006) 1.26
Evidence of MEN-2 in the original description of classic pheochromocytoma. N Engl J Med (2007) 1.24
Modern management of epilepsy: a practical approach. Epilepsy Behav (2008) 1.22
Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain (2009) 1.08
New horizons in the development of antiepileptic drugs. Epilepsy Res (2002) 1.00
New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res (2004) 1.00
The administration of rescue medication to children with prolonged acute convulsive seizures in the community: what happens in practice? Eur J Paediatr Neurol (2012) 0.96
Development of new treatment approaches for epilepsy: unmet needs and opportunities. Epilepsia (2013) 0.94
Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain (2008) 0.93
Issues related to development of antiepileptogenic therapies. Epilepsia (2013) 0.91
Long-term risks following first remission in childhood-onset epilepsy. A population-based study. Epilepsy Behav (2012) 0.89
Regional differences and secular trends in the incidence of epilepsy in Finland: a nationwide 23-year registry study. Epilepsia (2011) 0.87
Adjunctive Madopar for ultrarefractory epilepsy? Preliminary observations. Epilepsy Behav (2013) 0.87
Solitary juxtapapillary capillary retinal angioma and von Hippel-Lindau disease. Can J Ophthalmol (2007) 0.87
Epilepsy: perampanel-new promise for refractory epilepsy? Nat Rev Neurol (2012) 0.84
Is incident drug-resistance of childhood-onset epilepsy reversible? A long-term follow-up study. Brain (2012) 0.83
Color-coded sonography in suspected temporal arteritis-experiences after 83 cases. Rheumatol Int (2003) 0.83
Bodyweight gain under pregabalin therapy in epilepsy: mitigation by counseling patients? Seizure (2007) 0.83
Involvement of the vertebral arteries in giant cell arteritis mimicking vertebral dissection. J Neurol (2003) 0.82
Predicting antiepileptic drug response in children with epilepsy. Expert Rev Neurother (2011) 0.80
Long-term employment of adults with childhood-onset epilepsy: a prospective population-based study. Epilepsia (2010) 0.79
The administration of rescue medication to children with prolonged acute convulsive seizures in a non-hospital setting: an exploratory survey of healthcare professionals' perspectives. Eur J Pediatr (2014) 0.79
Placebo-corrected efficacy of modern nonenzyme-inducing AEDs for refractory focal epilepsy: systematic review and meta-analysis. Epilepsia (2012) 0.79
Geriatric epilepsy: research and clinical directions for the future. Epilepsy Behav (2011) 0.78
Vincenz Fukala (1847-1911) and the early history of clear-lens surgery in high myopia. J Refract Surg (2011) 0.78
Delayed time to first remission identifies poor long-term drug response of childhood-onset epilepsy: a prospective population-based study. Epilepsy Behav (2009) 0.78
Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy. Expert Rev Neurother (2014) 0.77
Seizing the moment for the future: the U.S. Anticonvulsant Screening Project. Epilepsia (2012) 0.77
Antiepileptic drugs: advantages and disadvantages. Handb Clin Neurol (2012) 0.77
First research on developmental ambloypia due to early deprivation--Hans Berger's experiments in 1900. Perception (2005) 0.77
Does surgery prevent worsening of epilepsy? Epilepsia (2013) 0.76
Some Additions. Dtsch Arztebl Int (2017) 0.75
Retinopathy as a differential diagnosis. Dtsch Arztebl Int (2011) 0.75
Commentary to Gregoris and Shorvon, Epilepsy & Behavior, 2013; (in this issue).: any real advances in clinical epilepsy over the last decades? Epilepsy Behav (2013) 0.75
Be sure to read the fine print: the agency for healthcare research and quality comparative effectiveness report on antiepileptic drugs. Epilepsy Curr (2012) 0.75
Downbeat and upbeat nystagmus. Dtsch Arztebl Int (2011) 0.75
Correspondence (letter to the editor): Avoid further transmission. Dtsch Arztebl Int (2012) 0.75
Are we failing to provide adequate rescue medication to children at risk of prolonged convulsive seizures in schools? Arch Dis Child (2013) 0.75
Authors' reply to the comments by Rheims et al., 2010. Epilepsia (2010) 0.75
Adults should be treated too. Dtsch Arztebl Int (2012) 0.75
Filamentary Keratitis as Indication. Dtsch Arztebl Int (2017) 0.75
Management of epilepsy: hope and hurdles--critical reviews and clinical guidance. Introduction. Epilepsy Behav (2009) 0.75
Increase in Glaucoma Patients. Dtsch Arztebl Int (2017) 0.75
Ocular Signs Should Be Given Attention. Dtsch Arztebl Int (2017) 0.75
Synopsis and outlook. Epilepsy Behav (2009) 0.75
Addenda. Dtsch Arztebl Int (2017) 0.75
A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency. Clin Chem Lab Med (2007) 0.75
[Michał Borysiekiewicz (1848-1899)--ophthalmology professor, head of departments in Innsbruck and Graz]. Klin Oczna (2014) 0.75
Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: clinical observations. Epilepsy Behav (2012) 0.75
Seizures. Introduction. Epilepsy Behav (2010) 0.75
Stopping antiepileptic drugs in seizure-free patients. Curr Opin Neurol (2014) 0.75